Saxo Bank’s Head of Equity Strategy Peter Garnry is looking to buy shares in Gilead Sciences...

Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

This week the New York Times, in an editorial, urged US lawmakers to legalise marijuana. Some...

Serge Berger suggests buying Biogen, a biotech firm which has reported sales of its Multiple...

AstraZeneca’s stock price tumbled 14 percent on Monday morning after the company rejected...

As the Astra Zeneca Pfizer deal gets more bad tempered and political, what are the side effects...

What next in the drama surrounding the proposed merger of pharmaceutical giants Pfizer and...